Log in to your Inderes Free account to see all free content on this page.
Abera Bioscience
6.30 SEK
Less than 1K followers
ABERA
Spotlight Stock Market
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Valuation
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Abera Bioscience
P/B
Median 2021-2025
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|
| Share price (SEK) | - | 16.55 | 4.80 | 5.16 | 4.51 | 6.80 |
| Shares | 10.5 | 11.6 | 12.9 | 14.5 | 15.4 | 18.6 |
| Market cap | - | 191.6 | 62.0 | 74.6 | 69.2 | 126.7 |
| Enterprise value | - | 179.6 | 46.5 | 71.3 | 63.1 | 103.2 |
| EV/S | - | - | - | - | - | - |
| EV/EBITDA | - | neg. | neg. | neg. | neg. | neg. |
| EV/EBIT | - | neg. | neg. | neg. | neg. | neg. |
| P/E | - | neg. | neg. | neg. | neg. | neg. |
| P/B | - | 6.57 | 3.69 | 13.19 | 8.00 | 6.57 |
| P/S | - | - | - | - | - | - |
| Dividend yield | - | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % |
| Equity ratio | 14.4 % | 92.9 % | 85.7 % | 60.5 % | 63.7 % | 67.5 % |
| Gearing ratio | - | - | - | - | - | - |
Login required
This content is only available for logged in users